Literature DB >> 11723390

An update on the leukodsytrophies.

R Schiffmann1, O Boespflüg-Tanguy.   

Abstract

This review centers on important recent advances in the understanding of the role of glial fibrillary acidic protein in Alexander disease and of proteolipid protein in hypomyelinating disorders such as Pelizaeus-Merzbacher and spastic paraplegia. We also describe seven novel leukodystrophies. These include childhood ataxia with central nervous system hypomyelination, a relatively common leukodystrophy syndrome with linkage to chromosome 3 in some patients, and megalencephalic leukoencephalopathy with subcortical cysts whose gene has recently been cloned. These, along with five other disorders, including leukodystrophy with polyol metabolism abnormality, demonstrate that an increasing number of protein and metabolic abnormalities can cause primary myelin disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11723390     DOI: 10.1097/00019052-200112000-00018

Source DB:  PubMed          Journal:  Curr Opin Neurol        ISSN: 1350-7540            Impact factor:   5.710


  8 in total

1.  PLP1 and GPM6B intragenic copy number analysis by MAPH in 262 patients with hypomyelinating leukodystrophies: Identification of one partial triplication and two partial deletions of PLP1.

Authors:  Patricia Combes; Marie-Noelle Bonnet-Dupeyron; Fernande Gauthier-Barichard; Raphael Schiffmann; Enrico Bertini; Diana Rodriguez; John A L Armour; Odile Boespflug-Tanguy; Catherine Vaurs-Barrière
Journal:  Neurogenetics       Date:  2006-01-17       Impact factor: 2.660

2.  A myelin-specific contrast agent for magnetic resonance imaging of myelination.

Authors:  Luca Frullano; Changning Wang; Robert H Miller; Yanming Wang
Journal:  J Am Chem Soc       Date:  2011-01-25       Impact factor: 15.419

Review 3.  Systematic approaches to central nervous system myelin.

Authors:  Patricia de Monasterio-Schrader; Olaf Jahn; Stefan Tenzer; Sven P Wichert; Julia Patzig; Hauke B Werner
Journal:  Cell Mol Life Sci       Date:  2012-03-23       Impact factor: 9.261

4.  Pelizaeus-Merzbacher-like disease is caused not only by a loss of connexin47 function but also by a hemichannel dysfunction.

Authors:  Simone Diekmann; Marco Henneke; Birgitta C Burckhardt; Jutta Gärtner
Journal:  Eur J Hum Genet       Date:  2010-05-05       Impact factor: 4.246

5.  Insertion of mutant proteolipid protein results in missorting of myelin proteins.

Authors:  Catherine Vaurs-Barriere; Kondi Wong; Thais D Weibel; Mones Abu-Asab; Michael D Weiss; Christine R Kaneski; Tong-Hui Mixon; Simona Bonavita; Isabelle Creveaux; John D Heiss; Maria Tsokos; Ehud Goldin; Richard H Quarles; Odile Boespflug-Tanguy; Raphael Schiffmann
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

6.  Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.

Authors:  Birgit Uhlenberg; Markus Schuelke; Franz Rüschendorf; Nico Ruf; Angela M Kaindl; Marco Henneke; Holger Thiele; Gisela Stoltenburg-Didinger; Fuat Aksu; Haluk Topaloğlu; Peter Nürnberg; Christoph Hübner; Bernhard Weschke; Jutta Gärtner
Journal:  Am J Hum Genet       Date:  2004-06-10       Impact factor: 11.025

7.  Mitochondrial hsp60 chaperonopathy causes an autosomal-recessive neurodegenerative disorder linked to brain hypomyelination and leukodystrophy.

Authors:  Daniella Magen; Costa Georgopoulos; Peter Bross; Debbie Ang; Yardena Segev; Dorit Goldsher; Alexandra Nemirovski; Eli Shahar; Sarit Ravid; Anthony Luder; Bayan Heno; Ruth Gershoni-Baruch; Karl Skorecki; Hanna Mandel
Journal:  Am J Hum Genet       Date:  2008-06-19       Impact factor: 11.025

8.  Molecular pathogenesis of megalencephalic leukoencephalopathy with subcortical cysts: mutations in MLC1 cause folding defects.

Authors:  Anna Duarri; Oscar Teijido; Tania López-Hernández; Gert C Scheper; Herve Barriere; Ilja Boor; Fernando Aguado; Antonio Zorzano; Manuel Palacín; Albert Martínez; Gergely L Lukacs; Marjo S van der Knaap; Virginia Nunes; Raúl Estévez
Journal:  Hum Mol Genet       Date:  2008-08-30       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.